期刊文献+

硼替佐米联合NK细胞对骨髓瘤细胞株KM-3作用的影响 被引量:1

Influence of bortezomib and NK cells on multiple myeloma cell line KM-3
原文传递
导出
摘要 目的:探讨硼替佐米联合自然杀伤(NK)细胞杀伤及诱导多发性骨髓瘤细胞株KM-3凋亡的作用。方法:WST-1法观察加入硼替佐米后,NK细胞对KM-3细胞杀伤作用的变化;Annexin-Ⅴ、PI及CD45三重免疫荧光标记,流式细胞术检测Annexin-Ⅴ+/PI-凋亡细胞及线粒体跨膜电位的变化。结果:效靶比为5∶1、10∶1和20∶1的NK细胞联合5nmol/L硼替佐米处理后12、24和48h,均显著杀伤KM-3细胞(P=0.003),杀伤率的升高呈时间依赖性(P=0.002),且显著高于NK细胞单独处理,P<0.01。效靶比为5∶1、10∶1和20∶1的NK细胞联合5nmol/L硼替佐米处理,Annexin-Ⅴ+/PI-细胞比例均增加(P=0.003),呈时间依赖性(P=0.002),且高于NK细胞单独处理,P<0.01。效靶比为5∶1、10∶1和20∶1的NK细胞联合5nmol/L硼替佐米处理后6、12和24h,KM-3细胞线粒体跨膜电位明显降低(P=0.025),呈时间依赖性(P=0.022),且低于NK细胞单独处理,P<0.05。结论:硼替佐米联合NK细胞具有更显著地杀伤并诱导KM-3细胞凋亡的作用,提示硼替佐米与NK细胞具有协同作用。 OBJECTIVE:To study the killing and inducing apoptotic effect of bortezomib and NK cells on multiple myeloma cell line KM-3. METHODS:WST-1 assay was used to observe the changes of the killing effect of KM-3 cells induced by NK cells and bortezomib. The changes of Annexin-Ⅴ+/PI-apoptotic cells and the mitochondrial transmembrane potential were examined by triplicate immunofluorescence of Annexin-Ⅴ,PI and CD45 and flowcytometry. RESULTS:NK cells (E:T ratio at 5:1,10:1,20:1) with 5 nmol/L bortezomib could significantly kill KM-3 cells after 12,24 and 48 hours (P=0.003). The growth killing rates increased in time dependence (P=0.002),which were higher than those of NK cells at the same time (P0.01). The Annexin-Ⅴ+/PI-cells increased in time dependence (P=0.002) and in dose dependence (P=0.003) when treated with NK cells (E:T ratio at 5:1,10:1,20:1) and 5 nmol/L bortezomib,which were higher than those of NK cells at the same time (P0.01). After 6,12 and 24 hours,the mitochondrial transmembrane potential of KM-3 cells treated with NK cells (E:T ratio at 5:1,10:1,20:1) and 5 nmol/L bortezomib significantly decreased (P=0.025) in time dependence (P=0.022),and the decreasing rates were higher than those of NK cells at the same time (P0.05). CONCLUSION:Bortezomib with NK cells can kill KM-3 cells and induce them apoptosis more significantly,which indicates that bortezomib and NK cells are synergistic.
出处 《中华肿瘤防治杂志》 CAS 2010年第17期1344-1347,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 杀伤细胞 天然 多发性骨髓瘤 细胞系 肿瘤 细胞凋亡 killer cells natural multiple myeloma cell line tumor apoptosis
  • 相关文献

参考文献9

  • 1黄朝晖,王丰,刘志辉,华东,李莉华,任金冬.人外周血细胞毒性CD3^-CD56^+ NK细胞高效扩增的研究[J].肿瘤防治研究,2004,31(1):36-38. 被引量:5
  • 2Zhou Q, Krebs J F, Salvesen G S. et al. Interaction of the baculovirus anti apoptotic protein p35 with caspase:specificiiy, kinetics, and characterization of the caspase/ p35 complex[J]. Biochemistry, 1998,37(56): 10757-10765.
  • 3Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis[J]. J Cell Biol, 1996,135(10) : 1441-1445.
  • 4Green DR, Reed J C. Mitochondria and apopmsis [J]. Science, 1998,281(5381):1309- 1312.
  • 5赵敬湘,王字玲.增强NK细胞肿瘤杀伤活性的研究进展[J].中华肿瘤防治杂志,2009,16(16):1267-1271. 被引量:11
  • 6Rajkumar S V, Richardson P G, Hideshima T, et al. Proteasome inhibition as a hovel therapeutic target in human canccr [J]. J Clin Oncol,2005,23(5):630 -639.
  • 7Spisek R, CharalambousA, Mazumder A, et al. Bortczomibell hances dendritic cell (DC) mediated induction of immunity to hu man myeloma via exposure of cell surface heat shock protein 90 on dying lumor cells: lherapeutic implications[J]. Blood, 2007, i09(24) : 1839-4845.
  • 8Richardson P G, Sonneveld P, Schuster M W. et al. Bortezomib or high dose dexamethasone for relapsed muhiple myeloma[J]. N Engl J Med,2005,352(13) :2487-2498.
  • 9JumeiS, GuidoJ. Tricot, TarunK,et al. Bortezomib down-regulates the cell -stirface expression of HLA class I and enhances natural killer cell mediated lysis of myeloma[J]. B1ood.2008, 111 (10):1309-1316.

二级参考文献39

  • 1周健,牛新清,梅家转,王杨,涂三芳,何颖芝,周雪云,郭坤元.同种异体NK细胞对不同肿瘤细胞的体外杀伤活性及其机制的初步探讨[J].现代免疫学,2008,28(1):7-11. 被引量:5
  • 2Suck G. Novel approaches using natural killer cells in cancer therapy[J].Semin Cancer Biol, 2006, 16(5):412-428.
  • 3Zamai L, Ponti C, Mirandola P, et al. NK cells and cancer [J]. J Immunol, 2007, 178(7):4011-4016.
  • 4Bryeeson Y T, Rudd E, Zheng C, et al. Defective eytotoxie lymphocyte degranulation in syntaxin-ll deWcient familial hemophagoeytie lymphohistiocytosis 4 (FHL4) patients [J].Blood, 2007, 110(5):1906 -1915.
  • 5Zhang C, Zhang J, Niu J, et al. Interteukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation[J]. Cytokine, 2008, 42(1):128 -136.
  • 6Hodge D L, Subleski J J, Reynolds D A, et al. The proinflammatory cytokine interleukin-18 alters multiple signaling path ways to inhibit natural killer cell death [J]. J Interferon Cytokine Res, 2006, 26(10):706-718.
  • 7Skak K, Frederiksen K S, Lundsgaard D. Interleukin-21 activates human natural killer cells and modulates their surface receptor expression[J]. Immunology, 2008, 123(4):575- 583.
  • 8Cooper M A, Fehniger T A, Ponnappan A, et al. Interleukin-1βcostimulates interferon-g production by human natural killer cells [J]. EurJ Immunol, 2001, 31(3): 792-801.
  • 9Roda J M, Parihar R, Magro C, et al. Natural killer cells produce T cell recruiting chemokines in response to antiboby-coated tumorcells[J]. Cancer Res, 2006, 66(1):517-526.
  • 10Roda J M, Joshi T, Butchar J P, et al. The activation of natural killer cell effector functions by eetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines[J]. Clin Cancer Res, 2007, 13(21):6419-6428.

共引文献14

同被引文献14

  • 1Casado J G, Pawelec G, Morgado S, et al. Expression of adhe sion molecules and ligands for activating and costimulatory re- ceptors involved in cell mediated cytotoxieity in a large panel of human melanoma cell lines[J]. Cancer Immunol Immunother, 2009,58(9) :1517-1526.
  • 2Stern-Ginossar N, Mandelboim O. An integrated view of the regula- tion of NKG2D ligands[J]. Immunology, 2009,128 (1) : 1-6.
  • 3Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses[J]. Immunol Rev, 2010,235 (1) : 267-285.
  • 4Das G, La Rocca R, Lakshmikanth T, et al. Monitoring human leukocyte antigen class I molecules by micro Raman spectroscopy at single-cell level[J]. J Biomed Opt,2010,15(2):027007.
  • 5Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells [J]. Immunol, 2006, 214(1) :130-142.
  • 6Li P, Morris DL, Willcox BE, et al. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like lig- and MICA[J]. Nat Immunol, 2001, 2(5):443-451.
  • 7Chen J C,Garba J A.Analyticcl model improvement using model test data[J].AIAA J,1980,18(6):684-690.
  • 8Berman A,Nagy E J.Improvement of a large analytical model using test data[J].AIAA J,1983,21(8):1168-1173.
  • 9Baruch M.Optimal correction of mass and stiffness matrices using measured modes[J].AIAA J,1982,20(11):1623-1626.
  • 10Wai Ming To.Application of singular value decomposition to direct matrix update method[J].AIAA J,1995,32(10):2124-2126.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部